{"transactions":[{"id":1289385,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T16:19:44.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":13158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F10","text":"These shares were issued to Mr. Lucido pursuant to the Director Agreement. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares Common Stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.38."}],"balance_after":2511940,"source":{"system":"sec-edgar","filing":"0001477932-25-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000598/form4.xml","form_type":"4"}},{"id":1289384,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T16:19:44.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":43860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"These shares were issued to Mr. Lucido pursuant the Service Agreement. As compensation for his services under the Service Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Service Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.38."}],"balance_after":2498782,"source":{"system":"sec-edgar","filing":"0001477932-25-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000598/form4.xml","form_type":"4"}},{"id":1289383,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T16:19:44.000Z","date":"2024-11-29","kind":"grant","planned":false,"acquired":true,"shares":55494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"These shares were issued to Mr. Lucido pursuant the Service Agreement. As compensation for his services under the Service Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Service Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.31."}],"balance_after":2454922,"source":{"system":"sec-edgar","filing":"0001477932-25-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000598/form4.xml","form_type":"4"}},{"id":1289382,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T16:19:44.000Z","date":"2024-10-31","kind":"grant","planned":false,"acquired":true,"shares":55556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"These shares were issued to Mr. Lucido pursuant the Service Agreement. As compensation for his services under the Service Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Service Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.30."}],"balance_after":2399428,"source":{"system":"sec-edgar","filing":"0001477932-25-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000598/form4.xml","form_type":"4"}},{"id":1289381,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T16:19:44.000Z","date":"2024-10-14","kind":"grant","planned":false,"acquired":true,"shares":1105218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"These shares were issued to Mr. Lucido pursuant to an exchange agreement by and between BioCorRx Inc. (the \"Company\") and Mr. Lucido dated October 14, 2024 (the \"October 2024 Exchange Agreement\"). Pursuant to the October 2024 Exchange Agreement, Mr. Lucido agreed to the exchange the aggregate amount of $387,6700 of director's fees and loans to a subsidiary of the Company for 1,105,218 shares of Common Stock at a price of $0.36 per share based on the underlying value of the Common Stock at the date of issuance."}],"balance_after":2343872,"source":{"system":"sec-edgar","filing":"0001477932-25-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000598/form4.xml","form_type":"4"}},{"id":1289380,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T16:19:44.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019 (the \"Director Agreement\"), by and between the Company and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares Common Stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.32."}],"balance_after":1238654,"source":{"system":"sec-edgar","filing":"0001477932-25-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000598/form4.xml","form_type":"4"}},{"id":1289379,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T16:19:44.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":52085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These shares were issued to Mr. Lucido pursuant the Service Agreement. As compensation for his services under the Service Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Service Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.32."}],"balance_after":1223029,"source":{"system":"sec-edgar","filing":"0001477932-25-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000598/form4.xml","form_type":"4"}},{"id":1289378,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T16:19:44.000Z","date":"2024-08-30","kind":"grant","planned":false,"acquired":true,"shares":55559,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares were issued to Mr. Lucido pursuant the Service Agreement. As compensation for his services under the Service Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Service Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.30."}],"balance_after":1170944,"source":{"system":"sec-edgar","filing":"0001477932-25-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000598/form4.xml","form_type":"4"}},{"id":1289377,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T16:19:44.000Z","date":"2024-07-31","kind":"grant","planned":false,"acquired":true,"shares":32092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were issued to Mr. Lucido pursuant the Service Agreement. As compensation for his services under the Service Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Service Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.5193."}],"balance_after":1115385,"source":{"system":"sec-edgar","filing":"0001477932-25-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000598/form4.xml","form_type":"4"}},{"id":1289376,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T16:19:44.000Z","date":"2024-04-24","kind":"other","planned":false,"acquired":true,"shares":460477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to an exchange agreement by and between BioCorRx Inc. (the \"Company\") and Mr. Lucido dated April 24, 2024 (the \"April 2024 Exchange Agreement\"). Pursuant to the April 2024 Exchange Agreement, Mr. Lucido agreed to the exchange of a promissory note then outstanding in the amount of $446,426 and the accrued interest on such promissory note of $7,858 and director fees of $90,000 for 460,477 shares of the Company's common stock, par value $0.001 per share (the \"Common Stock\") at a price of $1.18 per share based on the underlying value of the Common Stock at the date of issuance."}],"balance_after":1083293,"source":{"system":"sec-edgar","filing":"0001477932-25-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000598/form4.xml","form_type":"4"}},{"id":1456901,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2024-07-10T17:02:37.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":34016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were issued to Mr. Lucido pursuant to an Executive Service Agreement (the \"Agreement\"), dated January 5, 2024, by and between Company and Mr. Lucido. As compensation for his services under the Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.49."}],"balance_after":622816,"source":{"system":"sec-edgar","filing":"0001477932-24-004156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224004156/form4.xml","form_type":"4"}},{"id":1456900,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2024-07-10T17:02:37.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":10204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. (the \"Company\") and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock par value $0.001 per share (the \"Common Stock\") equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.49."}],"balance_after":588800,"source":{"system":"sec-edgar","filing":"0001477932-24-004156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224004156/form4.xml","form_type":"4"}},{"id":1495006,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2024-06-04T01:44:46.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":22831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to an Executive Service Agreement (the \"Agreement\"), dated January 5, 2024, by and between Company and Mr. Lucido. As compensation for his services under the Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.73."}],"balance_after":578596,"source":{"system":"sec-edgar","filing":"0001477932-24-003436","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224003436/form4.xml","form_type":"4"}},{"id":1531905,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2024-05-02T00:17:27.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":21552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to an Executive Service Agreement (the \"Agreement\"), dated January 5, 2024, by and between Company and Mr. Lucido. As compensation for his services under the Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Agreement, the number of shares Common Stock equivalent to $16,666.66 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.77."}],"balance_after":555765,"source":{"system":"sec-edgar","filing":"0001477932-24-002476","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224002476/form4.xml","form_type":"4"}},{"id":1549349,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2024-04-03T13:00:43.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":18553,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were issued to Mr. Lucido pursuant to an Executive Service Agreement (the \"Agreement\"), dated January 5, 2024, by and between Company and Mr. Lucido. As compensation for his services under the Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Agreement, the number of shares Common Stock equivalent to $16,666.66 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.90."}],"balance_after":534213,"source":{"system":"sec-edgar","filing":"0001477932-24-001820","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224001820/form4.xml","form_type":"4"}},{"id":1549348,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2024-04-03T13:00:43.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":5566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. (the \"Company\") and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock par value $0.001 per share (the \"Common Stock\") equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.90."}],"balance_after":515660,"source":{"system":"sec-edgar","filing":"0001477932-24-001820","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224001820/form4.xml","form_type":"4"}},{"id":1589004,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2024-03-08T00:42:39.000Z","date":"2024-02-29","kind":"grant","planned":false,"acquired":true,"shares":16892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were issued to Mr. Lucido pursuant to the Agreement. As compensation for his services under the Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Agreement, the number of shares of Common Stock equivalent to $16,666.66 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.98."}],"balance_after":510094,"source":{"system":"sec-edgar","filing":"0001477932-24-001093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224001093/form4.xml","form_type":"4"}},{"id":1589003,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2024-03-08T00:42:39.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":18269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to an Executive Service Agreement (the \"Agreement\"), dated January 5, 2024, by and between BioCorRx Inc. (the \"Company\") and Mr. Lucido. As compensation for his services under the Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Agreement, the number of shares of the Company's common stock, par value $0.001 per share (the \"Common Stock\"), equivalent to $16,666.66 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.80."}],"balance_after":493202,"source":{"system":"sec-edgar","filing":"0001477932-24-001093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224001093/form4.xml","form_type":"4"}},{"id":1677778,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Interim President"}}],"security":"Common Stock, par value $0.001","published_at":"2024-01-17T21:15:31.000Z","date":"2024-01-16","kind":"purchase","planned":false,"acquired":true,"shares":126,"price":0.7,"value":88.2,"ownership":{"direct":true},"balance_after":474933,"source":{"system":"sec-edgar","filing":"0001477932-24-000249","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224000249/form4.xml","form_type":"4"}},{"id":1677777,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Interim President"}}],"security":"Common Stock, par value $0.001","published_at":"2024-01-17T21:15:31.000Z","date":"2024-01-12","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":0.7,"value":2100.0,"ownership":{"direct":true},"balance_after":474807,"source":{"system":"sec-edgar","filing":"0001477932-24-000249","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224000249/form4.xml","form_type":"4"}},{"id":1687626,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2024-01-04T20:47:13.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":6173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.81."}],"balance_after":471807,"source":{"system":"sec-edgar","filing":"0001477932-24-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224000037/form4.xml","form_type":"4"}},{"id":1770323,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-10-02T20:50:07.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":2858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.75."}],"balance_after":465634,"source":{"system":"sec-edgar","filing":"0001477932-23-007296","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223007296/primary_doc.xml","form_type":"4"}},{"id":1835979,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-07-05T21:03:33.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":2891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.73."}],"balance_after":462776,"source":{"system":"sec-edgar","filing":"0001477932-23-005017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223005017/form4.xml","form_type":"4"}},{"id":1924930,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-04-05T20:15:42.000Z","date":"2023-04-03","kind":"other","planned":false,"acquired":true,"shares":183606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were issued to Mr. Lucido pursuant to an exchange agreement by and between BioCorRx Inc. (the \"Company\") and Mr. Lucido dated April 3, 2023 (the \"Exchange Agreement\"). Pursuant to the Exchange Agreement, the Company agreed to issue 183,606 shares of its common stock, par value $0.001 per share, to Mr. Lucido and Mr. Lucido agreed to exchange, surrender and cancel that certain promissory note dated November 1, 2022 held by Mr. Lucido in the aggregate amount of $313,892, including interest."}],"balance_after":459885,"source":{"system":"sec-edgar","filing":"0001477932-23-002273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223002273/form4.xml","form_type":"4"}},{"id":1924929,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-04-05T20:15:42.000Z","date":"2023-04-03","kind":"purchase","planned":false,"acquired":true,"shares":171296,"price":1.75,"value":299768.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to the Louis C Lucido and Carolyn M. Lucido, or their Successors, as Trustee of the Lucido Family Trust, Dated May 23, 2017, managed by Mr. Louis C Lucido (the \"Lucido Trust\") pursuant to a subscription agreement by and between BioCorRx Inc. and the Lucido Trust dated March 29 2023, and paid for on April 3, 2023. The Reporting Person may be deemed to have investment power over the Lucido Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares were issued to the Louis C Lucido and Carolyn M. Lucido, or their Successors, as Trustee of the Lucido Family Trust, Dated May 23, 2017, managed by Mr. Louis C Lucido (the \"Lucido Trust\") pursuant to a subscription agreement by and between BioCorRx Inc. and the Lucido Trust dated March 29 2023, and paid for on April 3, 2023. The Reporting Person may be deemed to have investment power over the Lucido Trust."}],"balance_after":276279,"source":{"system":"sec-edgar","filing":"0001477932-23-002273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223002273/form4.xml","form_type":"4"}},{"id":1932249,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-04-03T22:29:37.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":2824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.77."}],"balance_after":104983,"source":{"system":"sec-edgar","filing":"0001477932-23-002226","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223002226/form4.xml","form_type":"4"}},{"id":2040227,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-31T21:15:46.000Z","date":"2023-01-30","kind":"purchase","acquired":true,"shares":100,"price":1.37,"value":137.0,"ownership":{"direct":true},"balance_after":102159,"source":{"system":"sec-edgar","filing":"0001477932-23-000644","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000644/form4.xml","form_type":"4"}},{"id":2040226,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-31T21:15:46.000Z","date":"2023-01-30","kind":"purchase","acquired":true,"shares":300,"price":1.39,"value":417.0,"ownership":{"direct":true},"balance_after":102059,"source":{"system":"sec-edgar","filing":"0001477932-23-000644","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000644/form4.xml","form_type":"4"}},{"id":2043640,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-27T21:15:31.000Z","date":"2023-01-26","kind":"purchase","acquired":true,"shares":500,"price":1.293,"value":646.5,"ownership":{"direct":true},"balance_after":101759,"source":{"system":"sec-edgar","filing":"0001477932-23-000587","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000587/form4.xml","form_type":"4"}},{"id":2046359,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-25T19:32:34.000Z","date":"2023-01-24","kind":"purchase","acquired":true,"shares":200,"price":1.2,"value":240.0,"ownership":{"direct":true},"balance_after":101259,"source":{"system":"sec-edgar","filing":"0001477932-23-000530","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000530/form4.xml","form_type":"4"}},{"id":2053686,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-17T21:15:17.000Z","date":"2023-01-13","kind":"purchase","acquired":true,"shares":2000,"price":1.15,"value":2300.0,"ownership":{"direct":true},"balance_after":101059,"source":{"system":"sec-edgar","filing":"0001477932-23-000335","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000335/form4.xml","form_type":"4"}},{"id":2053685,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-17T21:15:17.000Z","date":"2023-01-13","kind":"purchase","acquired":true,"shares":2000,"price":1.1,"value":2200.0,"ownership":{"direct":true},"balance_after":99059,"source":{"system":"sec-edgar","filing":"0001477932-23-000335","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000335/form4.xml","form_type":"4"}},{"id":2067074,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-04T21:16:00.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":2000,"price":1.1,"value":2200.0,"ownership":{"direct":true},"balance_after":97059,"source":{"system":"sec-edgar","filing":"0001477932-23-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000088/form4.xml","form_type":"4"}},{"id":2067073,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-04T21:16:00.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":5319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.94"}],"balance_after":95059,"source":{"system":"sec-edgar","filing":"0001477932-23-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000088/form4.xml","form_type":"4"}},{"id":2067072,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-04T21:16:00.000Z","date":"2022-12-30","kind":"purchase","acquired":true,"shares":115,"price":1.03,"value":118.45,"ownership":{"direct":true},"balance_after":89740,"source":{"system":"sec-edgar","filing":"0001477932-23-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000088/form4.xml","form_type":"4"}},{"id":2067071,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-04T21:16:00.000Z","date":"2022-12-30","kind":"purchase","acquired":true,"shares":200,"price":0.975,"value":195.0,"ownership":{"direct":true},"balance_after":89625,"source":{"system":"sec-edgar","filing":"0001477932-23-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000088/form4.xml","form_type":"4"}},{"id":2085029,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-12-15T12:29:18.000Z","date":"2022-12-12","kind":"purchase","acquired":true,"shares":2000,"price":0.8,"value":1600.0,"ownership":{"direct":true},"balance_after":89425,"source":{"system":"sec-edgar","filing":"0001477932-22-009312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222009312/form4.xml","form_type":"4"}},{"id":2085028,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-12-15T12:29:18.000Z","date":"2022-12-12","kind":"purchase","acquired":true,"shares":1000,"price":0.8,"value":800.0,"ownership":{"direct":true},"balance_after":87425,"source":{"system":"sec-edgar","filing":"0001477932-22-009312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222009312/form4.xml","form_type":"4"}},{"id":2085027,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-12-15T12:29:18.000Z","date":"2022-12-12","kind":"purchase","acquired":true,"shares":1000,"price":0.98,"value":980.0,"ownership":{"direct":true},"balance_after":86425,"source":{"system":"sec-edgar","filing":"0001477932-22-009312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222009312/form4.xml","form_type":"4"}},{"id":2085026,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-12-15T12:29:18.000Z","date":"2022-12-12","kind":"purchase","acquired":true,"shares":1000,"price":0.79,"value":790.0,"ownership":{"direct":true},"balance_after":85425,"source":{"system":"sec-edgar","filing":"0001477932-22-009312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222009312/form4.xml","form_type":"4"}},{"id":2139130,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-10-11T21:59:50.000Z","date":"2022-10-06","kind":"purchase","acquired":true,"shares":100,"price":1.73,"value":173.0,"ownership":{"direct":true},"balance_after":84425,"source":{"system":"sec-edgar","filing":"0001477932-22-007543","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222007543/form4.xml","form_type":"4"}},{"id":2139129,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-10-11T21:59:50.000Z","date":"2022-10-06","kind":"purchase","acquired":true,"shares":120,"price":1.9,"value":228.0,"ownership":{"direct":true},"balance_after":84325,"source":{"system":"sec-edgar","filing":"0001477932-22-007543","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222007543/form4.xml","form_type":"4"}},{"id":2139128,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-10-11T21:59:50.000Z","date":"2022-10-06","kind":"purchase","acquired":true,"shares":360,"price":1.9,"value":684.0,"ownership":{"direct":true},"balance_after":84205,"source":{"system":"sec-edgar","filing":"0001477932-22-007543","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222007543/form4.xml","form_type":"4"}},{"id":2139127,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-10-11T21:59:50.000Z","date":"2022-10-05","kind":"purchase","acquired":true,"shares":1000,"price":2.02,"value":2020.0,"ownership":{"direct":true},"balance_after":83845,"source":{"system":"sec-edgar","filing":"0001477932-22-007543","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222007543/form4.xml","form_type":"4"}},{"id":2139126,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-10-11T21:59:50.000Z","date":"2022-09-06","kind":"purchase","acquired":true,"shares":10,"price":2.1,"value":21.0,"ownership":{"direct":true},"balance_after":82845,"source":{"system":"sec-edgar","filing":"0001477932-22-007543","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222007543/form4.xml","form_type":"4"}},{"id":2142138,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-10-05T20:08:28.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":2450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $2.04."}],"balance_after":82835,"source":{"system":"sec-edgar","filing":"0001477932-22-007471","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222007471/form4.xml","form_type":"4"}},{"id":2169902,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-08-31T23:15:13.000Z","date":"2022-08-31","kind":"purchase","acquired":true,"shares":610,"price":2.12,"value":1293.2,"ownership":{"direct":true},"balance_after":80385,"source":{"system":"sec-edgar","filing":"0001477932-22-006572","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222006572/form4.xml","form_type":"4"}},{"id":2169901,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-08-31T23:15:13.000Z","date":"2022-08-29","kind":"purchase","acquired":true,"shares":2268,"price":2.1,"value":4762.8,"ownership":{"direct":true},"balance_after":79775,"source":{"system":"sec-edgar","filing":"0001477932-22-006572","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222006572/form4.xml","form_type":"4"}},{"id":2169900,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-08-31T23:15:13.000Z","date":"2022-08-29","kind":"purchase","acquired":true,"shares":1000,"price":2.12,"value":2120.0,"ownership":{"direct":true},"balance_after":77507,"source":{"system":"sec-edgar","filing":"0001477932-22-006572","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222006572/form4.xml","form_type":"4"}},{"id":2171746,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-08-29T16:16:34.000Z","date":"2022-08-26","kind":"purchase","acquired":true,"shares":560,"price":2.12,"value":1187.2,"ownership":{"direct":true},"balance_after":76507,"source":{"system":"sec-edgar","filing":"0001477932-22-006484","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222006484/form4.xml","form_type":"4"}},{"id":2171745,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-08-29T16:16:34.000Z","date":"2022-08-25","kind":"purchase","acquired":true,"shares":500,"price":2.18,"value":1090.0,"ownership":{"direct":true},"balance_after":75947,"source":{"system":"sec-edgar","filing":"0001477932-22-006484","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222006484/form4.xml","form_type":"4"}},{"id":2210714,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-07-07T22:06:36.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":2092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $2.39."}],"balance_after":75447,"source":{"system":"sec-edgar","filing":"0001477932-22-004884","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222004884/form4.xml","form_type":"4"}},{"id":2308012,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-04-04T22:37:20.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":1408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $3.55."}],"balance_after":73355,"source":{"system":"sec-edgar","filing":"0001477932-22-002042","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222002042/form4.xml","form_type":"4"}},{"id":2360396,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-03-02T20:10:13.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":1141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $4.38."}],"balance_after":71947,"source":{"system":"sec-edgar","filing":"0001477932-22-001167","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222001167/form4.xml","form_type":"4"}},{"id":2535489,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2021-10-25T20:10:57.000Z","date":"2021-10-19","kind":"purchase","acquired":true,"shares":1550,"price":3.2,"value":4960.0,"ownership":{"direct":true},"balance_after":70806,"source":{"system":"sec-edgar","filing":"0001477932-21-007564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793221007564/form4.xml","form_type":"4"}},{"id":2535488,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2021-10-25T20:10:57.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":1381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $3.62."}],"balance_after":68536,"source":{"system":"sec-edgar","filing":"0001477932-21-007564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793221007564/form4.xml","form_type":"4"}},{"id":2633997,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2021-07-14T15:51:30.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":1210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $4.13."}],"balance_after":67155,"source":{"system":"sec-edgar","filing":"0001477932-21-004602","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793221004602/form4.xml","form_type":"4"}},{"id":2761092,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2021-04-02T17:44:55.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":2315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $2.16."}],"balance_after":65945,"source":{"system":"sec-edgar","filing":"0001477932-21-002009","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793221002009/form4.xml","form_type":"4"}},{"id":2819839,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2021-03-02T18:23:11.000Z","date":"2021-02-26","kind":"purchase","acquired":true,"shares":562500,"price":2,"value":1125000.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares were issued to the Louis C Lucido and Carolyn M. Lucido, or their Successors, as Trustee of the Lucido Family Trust, Dated May 23, 2017 (the \"Lucido Trust\") pursuant to a subscription agreement by and between BioCorRx Inc. and the Lucido Trust dated February 16, 2021, fully executed on February 23, 2021, and paid for on February 26, 2020. The Reporting Person may be deemed to have investment power over the Lucido Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares were issued to the Louis C Lucido and Carolyn M. Lucido, or their Successors, as Trustee of the Lucido Family Trust, Dated May 23, 2017 (the \"Lucido Trust\") pursuant to a subscription agreement by and between BioCorRx Inc. and the Lucido Trust dated February 16, 2021, fully executed on February 23, 2021, and paid for on February 26, 2020. The Reporting Person may be deemed to have investment power over the Lucido Trust."}],"balance_after":562500,"source":{"system":"sec-edgar","filing":"0001477932-21-001163","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793221001163/form4.xml","form_type":"4"}},{"id":2819838,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2021-03-02T18:23:11.000Z","date":"2021-01-22","kind":"purchase","acquired":true,"shares":2000,"price":1.44,"value":2880.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in three transactions at prices ranging from $1.40 to $1.45 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Due to a clerical error in the Form 4 filed by the reporting person on January 5, 2021, the Form 4 incorrectly stated that the reporting person owned 261,926 shares directly. In fact, as of January 5, 2021, the reporting person owned 61,630 shares directly and 200,000 shares indirectly through Louis and Carolyn Lucido CRT LLC (the \"LLC\"). The difference of 296 shares was due to the aforesaid clerical error, which the reporting person did not discover until now. This Form 4 corrects the aforesaid errors in Table 1, Column 5. Following the reported transactions on January 22, 2021, the reporting person currently owns 63,630 shares directly."}],"balance_after":63630,"source":{"system":"sec-edgar","filing":"0001477932-21-001163","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793221001163/form4.xml","form_type":"4"}},{"id":3008122,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2020-10-13T22:36:06.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":2631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.90."}],"balance_after":257025,"source":{"system":"sec-edgar","filing":"0001477932-20-005862","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793220005862/form4.xml","form_type":"4"}}]}